惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

H
Help Net Security
宝玉的分享
宝玉的分享
The Cloudflare Blog
Apple Machine Learning Research
Apple Machine Learning Research
V
Visual Studio Blog
Last Week in AI
Last Week in AI
Hugging Face - Blog
Hugging Face - Blog
博客园 - 司徒正美
博客园 - 三生石上(FineUI控件)
A
About on SuperTechFans
MyScale Blog
MyScale Blog
aimingoo的专栏
aimingoo的专栏
Microsoft Security Blog
Microsoft Security Blog
D
Docker
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
Recent Announcements
Recent Announcements
大猫的无限游戏
大猫的无限游戏
IT之家
IT之家
P
Proofpoint News Feed
L
LangChain Blog
Blog — PlanetScale
Blog — PlanetScale
The GitHub Blog
The GitHub Blog
博客园 - 【当耐特】
Martin Fowler
Martin Fowler

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
MediPharm Labs Corp. (LABS:CA) Shareholder/Analyst Call P...
SA Transcripts · 2026-06-18 · via All Articles on Seeking Alpha

MediPharm Labs Corp. (LABS:CA) Shareholder/Analyst Call June 17, 2026 11:00 AM EDT

Company Participants

Keith Strachan - Co-Founder & Director

Presentation

Operator

Welcome to the 2026 Annual and Special Meeting of Shareholders of MediPharm Labs Corp. Please note that the meeting is being recorded. I would like to introduce Keith Strachan, Chair of today's meeting. Mr. Strachan, the floor is yours.

Keith Strachan
Co-Founder & Director

Good morning. It's now 11:00 a.m. My name is Keith Strachan. I'm a Co-Founder and Director with MediPharm Labs. I will act as Chair of today's meeting on behalf of Board and management, including Greg Hunter, Interim CEO and CFO; and Ifeoluwa Adegebo, Corporate Controller, who are also in attendance with me. I am pleased to welcome you to the Annual and Special Meeting of Shareholders of MediPharm Labs Corp. We are pleased to host the meeting through this virtual platform accessible to all shareholders regardless of physical location.

As this meeting is being held online via live webcast, it is appropriate to set out a few guidelines for online participants for orderly conduct of this meeting. Questions can only be submitted by registered shareholders and duly appointed proxy holders entitled to attend and vote at the meeting. Questions may be submitted by selecting the Ask a Question button on the left side of your screen. Questions submitted in respect of motions, if any, will be addressed prior to the close of voting. Questions with respect to MediPharm Labs generally will be answered after the completion of management's closing remarks following the formal business.

For the purposes of meeting today, voting on all matters will be conducted by online ballot to the facilities of this webcast. If you're a registered shareholder or a duly appointed proxy holder who has logged in with a valid control